Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Kath Kerry

- PMLiVE

White House unveils plans to reimport medicines from Canada

Unthinkable to previous administrations, but scepticism rife amid flurry of policy ideas

Infographic: China: How to keep up and win in the world’s fastest changing healthcare market

Our latest infographic outlines the changes to the clinical trial process, accelerated drug approval, fast track of rare disease products and access opportunities in China's evolving healthcare environment.Find out more here-...

Inizio

- PMLiVE

Leiden reassures on key role at Vertex

Reshma Kewalramani to be new CEO, but Leiden will retain portfolio

Event: Richard Head presented with MR Excellence award at EphMRA Conference

Research Partnership were delighted to exhibit, sponsor and present three papers at the EphMRA conference where Director Richard Head was presented with one of this year's MR Excellence Awards.Find out...

Inizio

- PMLiVE

UK sets aside £2.1bn for more no-deal Brexit prep

£434m for medicine continuity

Spotlight interview: 15 minutes on the procurement function in pharma

Carwyn Jones, Senior Partner at OPEN Health, takes 15 minutes to answer some key questions on the procurement function in pharma.

OPEN Health

- PMLiVE

Who’s calling the shots in European healthcare?

Patients versus Pharma: industry too powerful, and too cosy with EMA, says Yannis Natsis

Novartis day

Blow for Entresto in latest heart failure trial

Aim of being first in HFpEF in serious doubt

- PMLiVE

Bayer taps Sensyne Health AI and real world data for cardiovascular research

Sensyne a ‘docking station’ for anonymised NHS patient data analysis

- PMLiVE

Mega-mergers dominate as buoyant markets lift biopharma

BridgeBio records biggest flotation in H1

Celgene building

Triplet approvals for myeloma boost Celgene in Q2

Surge in approvals and pipeline as merger nears

Bayer symbol

Bayer bags FDA nod for early prostate cancer drug darolutamide

new competition in the market

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links